GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (NAS:ADXN) » Definitions » Price-to-Funds-From-Operations

ADXN (Addex Therapeutics) Price-to-Funds-From-Operations : (As of Apr. 15, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Addex Therapeutics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Addex Therapeutics Business Description

Traded in Other Exchanges
Address
Chemin des Mines 9, Geneva, CHE, 1202
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.